RxDoctor Payments Data

Sonia Watley, MD

Family Medicine · Adairsville, GANPI 1770878498

Payments from drug & device makers

$4,477in general payments, 2019–2025

Across 259 payments — averaging $17.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$974
  • Lilly USA, LLC$600
  • Pfizer$493
  • AbbVie$454
  • GSK$328
  • Exact Sciences$242
  • plus $1K from 31 others

What the payments were for

  • Food & beverage$4,477100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,477 in reported general payments places this provider in the 80th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$41,780
Medicare patients
114
Services billed
622

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide73$65,736
RybelsusSemaglutide30$44,622
JardianceEmpagliflozin39$41,141
MounjaroTirzepatide33$34,505
FarxigaDapagliflozin Propanediol23$25,624
EliquisApixaban27$21,212
Trelegy ElliptaFluticasone/Umeclidin/Vilanter30$20,951
TrulicityDulaglutide16$15,616
JanuviaSitagliptin Phosphate11$12,561
EntrestoSacubitril/Valsartan15$9,737
LinzessLinaclotide13$6,420
Breo ElliptaFluticasone/Vilanterol12$4,556
Budesonide12$2,041
Albuterol Sulfate HfaAlbuterol Sulfate54$1,675
Atorvastatin Calcium264$1,605

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$974$110,358103 claims
Lilly USA, LLCMounjaro, Trulicity$600$50,12149 claims
Boehringer IngelheimJardiance$87$41,14139 claims
AstraZenecaFarxiga$108$25,62423 claims
GSKTrelegy Ellipta, Breo Ellipta$328$25,50842 claims
PfizerEliquis$493$21,21227 claims
MerckJanuvia$51$12,56111 claims
NovartisEntresto$32$9,73715 claims
AbbVieLinzess$454$6,42013 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Adairsville

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →